Senores Pharmaceuticals Limited has extended the time period for the acquisition of the remaining 540 equity shares of Havix Group Inc. D/B/A Aavis Pharmaceuticals by 60 days from June 24, 2025.
This extension is due to pending approvals from the Reserve Bank of India (RBI).
Senores Pharmaceuticals had earlier intimated on March 11, 2025, March 12, 2025, and April 22, 2025, regarding the acquisition of 8,454 equity shares from certain shareholders of Havix Group Inc., out of which 7,914 equity shares have already been acquired.